Talacen

   
Google
 
Web NewDrugInformation.com

Talacen


Drug - Talacen
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Acetaminophen; Pentazocine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 650MG;EQ 25MG BASE
The potency of the active ingredient(s), Acetaminophen; Pentazocine Hydrochloride. May repeat for multiple part products.

Applicant - SANOFI SYNTHELABO
The firm name holding legal responsibility for Talacen. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018458
The FDA assigned number to Talacen. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Talacen. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 23, 1982
The date Talacen was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Talacen. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Talacen is in. Format is RX, OTC, DISCN.

Applicant Full Name - Sanofi Synthelabo Inc
The full name of the firm holding legal responsibility for the new application of Talacen.

Talacen